Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer...
Allogene Therapeutics’ CAR-T treatment eliminates residual cancer cells in B-cell lymphoma patients
Allogene Therapeutics said Monday that its off-the-shelf CAR-T treatment eliminated residual cancer cells in patients with B-cell lymphoma three times...
Author: statnews.com
Read Original Article